Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Gestační diabetes - modelová studie. (Vliv aloxanového diabetu na spektrum mastných kyselin v krevním séru, v játrech a v mozku u laboratorního potkana)
[Gestational diabetes - model trial]

J. Mourek, L. Šmídová, V. Šlapetová

. 1998 ; Roč. 63 (č. 3) : s. 202-206.

Jazyk čeština Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc98014302

Grantová podpora
IZ3293 MZ0 CEP - Centrální evidence projektů

In alloxan-induced diabetic rats (Wistar, females, age 3-4 months of postnatal life) the large spectrum of fatty acids in blood serum, brain cortex, medulla oblongata and liver was studied. The fatty acids, using gas chromatography, were detected as methyl esters and the methods were published previously (Šmídová and al. 1994). Alloxan (Merck) administered i.p., 140 mg/kg body weight, caused immediately elevation (three times) of blood sugar levels. On the 13th day the rats were killed. The results are as follows: a) In blood serum alloxan diabetes of cca two weeks duration caused a significantly increased participation of saturated FA and decreased participation of both polyunsaturated FA (n-3 and n-6). b) In brain cortex no differences between controls and diabetic rats in the indicated groups of FA were found. c) In the medulla oblongata an increased participation of polyunsaturated fatty acids n-6 was established. d) In hepatic tissue the increased participation of saturated FA as well as a decreased participation of FA n-6 was described. Analysing the main groups of FA we found especially in n-3 and n-6 FA several significant changes in single FA (a smaller pool of arachidonic acid in blood serum as well as in liver, decreased participation of docosahexaenoic acid in the brain cortex, etc.). The purpose and possible consequences of such changes are discussed.

Gestational diabetes - model trial

Gestační diabetes - modelová studie. (Vliv aloxanového diabetu na spektrum mastných kyselin v krevním séru, v játrech a v mozku u laboratorního potkana) = Gestational diabetes - model trial /

Bibliografie atd.

Lit: 27

Bibliografie atd.

Souhrn en

000      
00000naa a2200000 a 4500
001      
bmc98014302
003      
CZ-PrNML
005      
20211118103312.0
008      
980900s1998 xr u cze||
009      
AR
035    __
$a (PubMed)9750381
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Mourek, Jindřich, $d 1928- $4 aut $7 jk01082206
245    10
$a Gestační diabetes - modelová studie. (Vliv aloxanového diabetu na spektrum mastných kyselin v krevním séru, v játrech a v mozku u laboratorního potkana) = $b Gestational diabetes - model trial / $c J. Mourek, L. Šmídová, V. Šlapetová
246    11
$a Gestational diabetes - model trial
314    __
$a UK. 1. LF. Fyziologický ústav, Praha, CZ
504    __
$a Lit: 27
504    __
$a Souhrn en
520    9_
$a In alloxan-induced diabetic rats (Wistar, females, age 3-4 months of postnatal life) the large spectrum of fatty acids in blood serum, brain cortex, medulla oblongata and liver was studied. The fatty acids, using gas chromatography, were detected as methyl esters and the methods were published previously (Šmídová and al. 1994). Alloxan (Merck) administered i.p., 140 mg/kg body weight, caused immediately elevation (three times) of blood sugar levels. On the 13th day the rats were killed. The results are as follows: a) In blood serum alloxan diabetes of cca two weeks duration caused a significantly increased participation of saturated FA and decreased participation of both polyunsaturated FA (n-3 and n-6). b) In brain cortex no differences between controls and diabetic rats in the indicated groups of FA were found. c) In the medulla oblongata an increased participation of polyunsaturated fatty acids n-6 was established. d) In hepatic tissue the increased participation of saturated FA as well as a decreased participation of FA n-6 was described. Analysing the main groups of FA we found especially in n-3 and n-6 FA several significant changes in single FA (a smaller pool of arachidonic acid in blood serum as well as in liver, decreased participation of docosahexaenoic acid in the brain cortex, etc.). The purpose and possible consequences of such changes are discussed.
650    _2
$a gestační diabetes $x patologie $7 D016640
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a zvířata $7 D000818
650    _2
$a krysa rodu Rattus $7 D051381
700    1_
$a Šmídová, L. $4 aut
700    1_
$a Šlapetová, V. $4 aut
700    1_
$a Krejčí, V. $4 aut
700    1_
$a Plavka, Richard, $d 1957- $4 aut $7 xx0084863
773    0_
$w MED00010981 $t Česká gynekologie $g Roč. 63, č. 3 (1998), s. 202-206 $x 1210-7832
910    __
$a ABA008 $b A 4086 $c 310 $y 0 $z 0
990    __
$a 20060602 $b ABA008
991    __
$a 20211118103314 $b ABA008
BAS    __
$a 3
BMC    __
$a 1998 $b Roč. 63 $c č. 3 $d s. 202-206 $i 1210-7832 $m Česká gynekologie $x MED00010981
GRA    __
$a IZ3293 $p MZ0
LZP    __
$b přidání abstraktu

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...